These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 16312044

  • 1. CIITA transformation rescues the apoptotic function of MHC class II in melanoma cells.
    Le E, Zhang H, Blanck G.
    Anticancer Res; 2005; 25(6B):3889-92. PubMed ID: 16312044
    [Abstract] [Full Text] [Related]

  • 2. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA, Rimsza LM, Murphy SP.
    Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ.
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [Abstract] [Full Text] [Related]

  • 4. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
    van der Stoep N, Quinten E, Alblas G, Plancke A, van Eggermond MC, Holling TM, van den Elsen PJ.
    Mol Immunol; 2007 Mar; 44(8):2036-46. PubMed ID: 17067677
    [Abstract] [Full Text] [Related]

  • 5. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases.
    Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R, Alcaide-Loridan C.
    Eur J Immunol; 2007 Mar; 37(3):788-97. PubMed ID: 17304627
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M, Jager M, Ono SJ.
    Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
    [Abstract] [Full Text] [Related]

  • 7. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
    Takamura Y, Ikeda H, Kanaseki T, Toyota M, Tokino T, Imai K, Houkin K, Sato N.
    Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870
    [Abstract] [Full Text] [Related]

  • 8. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.
    Bradley MB, Fernandez JM, Ungers G, Diaz-Barrientos T, Steimle V, Mach B, O'Reilly R, Lee JS.
    J Immunol; 1997 Aug 01; 159(3):1086-95. PubMed ID: 9233601
    [Abstract] [Full Text] [Related]

  • 9. Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.
    Thompson JA, Dissanayake SK, Ksander BR, Knutson KL, Disis ML, Ostrand-Rosenberg S.
    Cancer Res; 2006 Jan 15; 66(2):1147-54. PubMed ID: 16424052
    [Abstract] [Full Text] [Related]

  • 10. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM, Blanck G.
    Cell Growth Differ; 2001 Jun 15; 12(6):327-35. PubMed ID: 11432807
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N.
    J Immunol; 2009 Feb 15; 182(4):1799-809. PubMed ID: 19201831
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
    Shi B, Vinyals A, Alia P, Broceño C, Chen F, Adrover M, Gelpi C, Price JE, Fabra A.
    Int J Biochem Cell Biol; 2006 Feb 15; 38(4):544-62. PubMed ID: 16343978
    [Abstract] [Full Text] [Related]

  • 13. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE, Cooper S, Hangoc G, Chang CH.
    Exp Hematol; 2006 Aug 15; 34(8):1078-84. PubMed ID: 16863914
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, Suzuki H, Sasaki Y, Kanaseki T, Takamura Y, Soejima H, Urano T, Yanagihara K, Endo T, Hinoda Y, Fujita M, Hosokawa M, Sato N, Tokino T, Imai K.
    Oncogene; 2004 Nov 25; 23(55):8876-86. PubMed ID: 15467734
    [Abstract] [Full Text] [Related]

  • 15. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M, Whiteside TL, Kaufmann R, Seliger B.
    Arch Dermatol Res; 2009 Feb 25; 301(2):189-93. PubMed ID: 19104823
    [Abstract] [Full Text] [Related]

  • 16. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.
    Lu Y, Boss JM, Hu SX, Xu HJ, Blanck G.
    J Immunol; 1996 Apr 01; 156(7):2495-502. PubMed ID: 8786310
    [Abstract] [Full Text] [Related]

  • 17. Prolonged MHC class II expression and CIITA transcription in human keratinocytes.
    Takagi A, Nishiyama C, Kanada S, Niwa Y, Fukuyama K, Ikeda S, Okumura K, Ogawa H.
    Biochem Biophys Res Commun; 2006 Aug 25; 347(2):388-93. PubMed ID: 16836979
    [Abstract] [Full Text] [Related]

  • 18. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L, Castellani P, Meazza R, Tosi G, De Lerma Barbaro A, Procopio FA, Comes A, Zardi L, Ferrini S, Accolla RS.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [Abstract] [Full Text] [Related]

  • 19. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A, Paliwal I, Lynch RJ, Bothwell AL, Hammond GL.
    Transplantation; 2003 Jul 27; 76(2):387-94. PubMed ID: 12883198
    [Abstract] [Full Text] [Related]

  • 20. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y, McDonald J, Perloff E, Butticè G, Schreiber BM, Smith BD.
    Mol Immunol; 2007 Mar 27; 44(7):1709-21. PubMed ID: 16982097
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.